Answers are grounded in this paper and cite their sources.
Treatment-resistant warts are a common and frustrating problem for patients, parents, and providers alike. No wart treatment is uniformly effective. Indeed, well-designed randomized controlled trials are sorely needed to establish the true efficacy of all wart therapies. Treatment should be tailored to each individual patient. Although none of the immunologically-based treatments listed above (see Table, page 377) is FDA-approved for warts, they provide the treating physician with options for patients with warts that are resistant to standard treatments.
No takes yet. Share an insight, caveat, or question.
Dasher et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: